ArticleNeurology. Clinical practice2013
Neurocysticercosis: Five new things.
Article in Neurology. Clinical practice, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 62 citations in OpenAlex.
- Solitary neurocysticercosis mimicking tuberculoma and glioblastoma: A diagnostic challenge in a low-resource setting.Surgical neurology international · 2026Article
- Identification of abnormal patterns of evolution of neurocysticercosis cysts and what they might indicate.medRxiv : the preprint server for health sciences · 2025Article
- Neurocysticercosis in non-endemic regions: The experience of Qatar.Frontiers in neurology · 2023Article
- To intervene or not to intervene: A case of symptomatic neurocysticercosis complicated by ventriculitis.IDCases · 2023Article
- Endoscope-assisted far lateral craniotomy for resection of posterior fossa neurocysticercosis: illustrative case.Journal of neurosurgery. Case lessons · 2022Article
- Helminthic dehydrogenase drives PGEEMBO reports · 2022Article
- Next-generation sequencing combined with serological tests based pathogen analysis for a neurocysticercosis patient with a 20-year history:a case report.BMC neurology · 2021Article
- Shigellosis Presenting as Meningism.Cureus · 2021Article
- Neurocysticercosis in Northern Peru: Qualitative Insights from men and women about living with seizures.PLoS neglected tropical diseases · 2020Article
- Zoonotic and vector-borne parasites and epilepsy in low-income and middle-income countries.Nature reviews. Neurology · 2020Review
- Histopathologic evaluation of experimental murine neurocysticercosis after treatment with albendazole/nitazoxanide combination.Parasitology · 2020Article
- Intrasellar cysticercosis cyst treated with a transciliary supraorbital keyhole approach - A case report.Surgical neurology international · 2020Article
- Clinicopathology conference: 41-year-old woman with chronic relapsing meningitis.Annals of neurology · 2019Article
- Present status of laboratory diagnosis of human taeniosis/cysticercosis in Europe.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2017Review
- Extraparenchymal neurocysticercosis: Demographic, clinicoradiological, and inflammatory features.PLoS neglected tropical diseases · 2017Article
- New diagnostic criteria for neurocysticercosis: Reliability and validity.Annals of neurology · 2016Article
- Parasitic diseases of the central nervous system: lessons for clinicians and policy makers.Expert review of neurotherapeutics · 2016Review
- Commentary.Journal of neurosciences in rural practice · 2014Article
- Commentary.Journal of neurosciences in rural practice · 2014Article
- Disseminated neurocysticercosis presenting as isolated acute monocular painless vision loss.Journal of neurosciences in rural practice · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neurocysticercosis is the most common parasitic brain disease worldwide. Its clinical heterogeneity is related to localization, number and stage of evolution of the parasites, sex, age, and intensity of the host brain inflammatory reaction. In addition to the localization of the parasite, inflammation is the main phenomenon responsible of symptomatology. Acute symptomatic seizures are the most common symptom in patients with parenchymal parasites, but most do not evolve into epilepsy. Neurocysticercosis diagnosis is based mainly on neuroimaging. New imaging techniques have improved detection of the scolex and visualization of cysts in the extraparenchymal spaces. Immunologic testing can be useful, particularly when imaging is equivocal. Based on disappearance of parasites, antihelminthic drugs as currently used are effective in approximately one-third of patients with parenchymal viable cysts.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.